Seed Fonds Aachen
VC Fund
Aachen, Germany
Seed Fonds Aachen is a VC fund in Aachen focused on Biotechnology and Health Care. Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Seed Fonds Aachen invests in
Stages Seed Fonds Aachen invests in
Countries Seed Fonds Aachen invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.1M–$1.6M
- Series A
- $2.2M–$8M
Investment Focus
Industry
- Biotechnology 5 (19%)
- Health Care 4 (15%)
- Medical 3 (12%)
- Software 3 (12%)
- Electronics 3 (12%)
Stage
- Seed 9 (35%)
- Venture - Series Unknown 7 (27%)
- Series A 3 (12%)
- Funding Round 3 (12%)
- Series B 2 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Markus Krückemeier
Managing Director
|
Managing Director | Total investments: 10 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Silexica was a venture capital backed company for software development tools. The SLX programming tools accelerate the journey from software to application-specific hardware systems and thus reduce time-to-market of intelligent products.Founded in 2014 as a spin-off from RWTH Aachen University, Silexica was headquartered in Germany with officesin the US and Japan. It has received $28M in venture capital funding from international investors and was acquired by Xilinx/AMD in 2021. | $18M / Series B / Jun 21, 2018 | ||
| Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile. | $2.2M / Series A / Jul 25, 2017 | ||
|
Innsystec
|
Hardware Software | Seed / Jun 07, 2017 | |
| Silexica was a venture capital backed company for software development tools. The SLX programming tools accelerate the journey from software to application-specific hardware systems and thus reduce time-to-market of intelligent products.Founded in 2014 as a spin-off from RWTH Aachen University, Silexica was headquartered in Germany with officesin the US and Japan. It has received $28M in venture capital funding from international investors and was acquired by Xilinx/AMD in 2021. | $8M / Series A / Nov 28, 2016 | ||
| antibodies-online is a global life science supplier providing researchers with access to high-quality reagents for protein-level research. The company operates a dual business model that combines its own development and manufacturing activities within the antibodies-online and Rockland group with a curated marketplace of third-party products fromestablished external suppliers. This integrated approach enables antibodies-online to offer both scientific depth and portfolio breadth through a single, reliable platform.The product portfolio spans more than 90,000 targets across over 2,000 species and supports more than 300 research applications. In addition to distributing reagents from a broad network of partners, antibodies-online is involved in the development of selected research tools under its own brand, supported by scientific validation and technical documentation. The company also offers custom protein development based on specific research requirements. Complementing this, custom antibody generation services are provided through Rockland Immunochemicals, Inc., leveraging Rockland’s in-house R&D and production capabilities.As part of the Rockland group, antibodies-online integrates manufacturing expertise, scientific know-how, and efficient global logistics with a strong focus on data quality, reproducibility, and technical support. Marketplace offerings and in-house activities are positioned as complementary components of a unified portfolio, designed to help researchers efficiently identify, source, and apply fit-for-purpose reagents.antibodies-online serves academic, biotech, and pharmaceutical research organizations worldwide, supporting basic research, translational science, and assay development. The company’s mission is to continually refine scientific expertise and operational excellence in order to deliver reliable research reagents and customized solutions that advance life science research and enable progress in diagnostics and therapeutics. antibodies-online.com currently operates out of three global offices in Limerick, PA (USA) and Aachen (Germany). The websites www.antibodies-online.com, www.antikoerper-online.de, www.anticorps-enligne.fr. | Venture - Series Unknown / Oct 21, 2016 | ||
| KLANG:technologies are here to offer a new and unique concert experience to musicians all over the world. They believe that musicians who feel comfortable on stage with their monitoring sound are able to perform better and connect with the band and audience more easily and freely.In-ear monitoring, a phenomenon which spread widely over the pastt decades, is a huge step in this direction. Musicians still hesitate to make the switch from wedges to in-ears - they are troubled with an unnatural sound, missing transparency, auditory fatigue and disorientation.With our 3D In-Ear Monitoring, they are striving to overcome those last obstacles on the way to a perfect monitoring sound. They want to bring back the naturalness in hearing for the musician on stage - the feeling, as if you are not wearing any in-ears at all. | Series B / Jul 07, 2016 | ||
| LogCom stands for the development, production, and distribution of software solutions and the devices and items required for running the programs. | Series C / Apr 26, 2016 | ||
| Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile. | $6M / Series A / Feb 10, 2016 | ||
| aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development. | Seed / Nov 10, 2015 | ||
| RLK Klimatechnik providing ventilation components from our own production and a diverse range of commercial products with high availability on the best terms - convince yourself as a retailer of our excellent product range. | Venture - Series Unknown / Apr 10, 2015 | ||
| See all 26 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Seed Fonds Aachen invest in?
Seed Fonds Aachen invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Venture - Series Unknown stage. Most of the 26 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Seed Fonds Aachen invest in?
Seed Fonds Aachen typically joins rounds of $1.1M–$1.6M at Seed and $2.2M–$8M at Series A. These are whole funding-round sizes, not Seed Fonds Aachen's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Seed Fonds Aachen took part in.
How do I contact Seed Fonds Aachen?
Public channels for Seed Fonds Aachen include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Seed Fonds Aachen?
The team at Seed Fonds Aachen includes Markus Krückemeier (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
